Found: 21
Select item for more details and to access through your institution.
Use of dual-energy computed tomography for the evaluation of calcinosis in patients with systemic sclerosis.
- Published in:
- Clinical Rheumatology, 2015, v. 34, n. 9, p. 1557, doi. 10.1007/s10067-015-2998-7
- By:
- Publication type:
- Article
Survival and Predictors of Mortality in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry.
- Published in:
- Arthritis Care & Research, 2014, v. 66, n. 3, p. 489, doi. 10.1002/acr.22121
- By:
- Publication type:
- Article
Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study.
- Published in:
- Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-1021-2
- By:
- Publication type:
- Article
Dose-escalation of human anti-interferon-alpha receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study.
- Published in:
- Arthritis Research & Therapy, 2014, v. 16, n. 1, p. 1, doi. 10.1186/ar4492
- By:
- Publication type:
- Article
Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study.
- Published in:
- Journal of Rheumatology, 2018, v. 45, n. 3, p. 405, doi. 10.3899/jrheum.161040
- By:
- Publication type:
- Article
Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment.
- Published in:
- Rheumatology, 2022, v. 61, n. 10, p. 4035, doi. 10.1093/rheumatology/keac126
- By:
- Publication type:
- Article
Inorganic pyrophosphate is reduced in patients with systemic sclerosis.
- Published in:
- Rheumatology, 2022, v. 61, n. 3, p. 1158, doi. 10.1093/rheumatology/keab508
- By:
- Publication type:
- Article
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
- Published in:
- Respiratory Research, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12931-022-02292-3
- By:
- Publication type:
- Article
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
- Published in:
- Respiratory Research, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12931-022-02292-3
- By:
- Publication type:
- Article
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
- Published in:
- Respiratory Research, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12931-022-02292-3
- By:
- Publication type:
- Article
Reply.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 8, p. 1350, doi. 10.1002/art.41294
- By:
- Publication type:
- Article
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 1, p. 125, doi. 10.1002/art.41055
- By:
- Publication type:
- Article
Brief Report: Whole‐Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 10, p. 1654, doi. 10.1002/art.40541
- By:
- Publication type:
- Article
Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial Hypertension.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 3, p. 740, doi. 10.1002/art.39478
- By:
- Publication type:
- Article
Are there risk factors for scleroderma-related calcinosis?
- Published in:
- Modern Rheumatology, 2018, v. 28, n. 3, p. 518, doi. 10.1080/14397595.2017.1349594
- By:
- Publication type:
- Article
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 9, p. 1608, doi. 10.1002/art.42510
- By:
- Publication type:
- Article
Adipose‐Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 8, p. 1399, doi. 10.1002/art.42133
- By:
- Publication type:
- Article
Echocardiogram: The GPS to GPA's Heart (Granulomatosis with Polyangiitis).
- Published in:
- Case Reports in Rheumatology, 2019, p. 1, doi. 10.1155/2019/7609386
- By:
- Publication type:
- Article